Stephens & Co. Reiterates Equal-Weight on Teladoc Health, Maintains $28 Price Target
Portfolio Pulse from richadhand@benzinga.com
Stephens & Co. analyst Jeff Garro has reiterated an Equal-Weight rating on Teladoc Health (NYSE:TDOC) and maintained a $28 price target.
July 26, 2023 | 3:48 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Stephens & Co. has reiterated an Equal-Weight rating on Teladoc Health and maintained a $28 price target.
The news is directly about Teladoc Health and its rating by Stephens & Co. The reiteration of the Equal-Weight rating and the maintenance of the $28 price target suggests that the analyst sees the stock as fairly valued at the moment. This could potentially have a neutral impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100